BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1163 related articles for article (PubMed ID: 33147993)

  • 1. Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension.
    Zawia A; Arnold ND; West L; Pickworth JA; Turton H; Iremonger J; Braithwaite AT; Cañedo J; Johnston SA; Thompson AAR; Miller G; Lawrie A
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):430-445. PubMed ID: 33147993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype and function of macrophage polarization in monocrotaline-induced pulmonary arterial hypertension rat model.
    Fan Y; Hao Y; Gao D; Li G; Zhang Z
    Physiol Res; 2021 Apr; 70(2):213-226. PubMed ID: 33676385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension.
    Abid S; Marcos E; Parpaleix A; Amsellem V; Breau M; Houssaini A; Vienney N; Lefevre M; Derumeaux G; Evans S; Hubeau C; Delcroix M; Quarck R; Adnot S; Lipskaia L
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31320454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.
    Batool M; Berghausen EM; Zierden M; Vantler M; Schermuly RT; Baldus S; Rosenkranz S; Ten Freyhaus H
    Basic Res Cardiol; 2020 Nov; 115(6):68. PubMed ID: 33188479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.
    Calvier L; Boucher P; Herz J; Hansmann G
    Circ Res; 2019 Jun; 124(12):1778-1785. PubMed ID: 31023188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin.
    Kinoshita D; Shishido T; Takahashi T; Yokoyama M; Sugai T; Watanabe K; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Kishida S; Kadomatsu K; Abe JI; Takeishi Y; Konta T; Kubota I; Watanabe M
    Sci Rep; 2020 Jun; 10(1):10345. PubMed ID: 32587339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
    Liu Y; Nie X; Zhu J; Wang T; Li Y; Wang Q; Sun Z
    J Cell Mol Med; 2021 Jan; 25(2):1221-1237. PubMed ID: 33340241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
    Vitry G; Paulin R; Grobs Y; Lampron MC; Shimauchi T; Lemay SE; Tremblay E; Habbout K; Awada C; Bourgeois A; Nadeau V; Paradis R; Breuils-Bonnet S; Roux-Dalvai F; Orcholski M; Potus F; Provencher S; Boucherat O; Bonnet S
    Am J Respir Crit Care Med; 2021 Mar; 203(5):614-627. PubMed ID: 33021405
    [No Abstract]   [Full Text] [Related]  

  • 12. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
    Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Yaku A; Inagaki T; Asano R; Okazawa M; Mori H; Sato A; Hia F; Masaki T; Manabe Y; Ishibashi T; Vandenbon A; Nakatsuka Y; Akaki K; Yoshinaga M; Uehata T; Mino T; Morita S; Ishibashi-Ueda H; Morinobu A; Tsujimura T; Ogo T; Nakaoka Y; Takeuchi O
    Circulation; 2022 Sep; 146(13):1006-1022. PubMed ID: 35997026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte and Alveolar Macrophage Skewing Is Associated with the Development of Pulmonary Arterial Hypertension in a Primate Model of HIV Infection.
    Schweitzer F; Tarantelli R; Rayens E; Kling HM; Mattila JT; Norris KA
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):63-74. PubMed ID: 30229666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress.
    Zhuan B; Wang X; Wang MD; Li ZC; Yuan Q; Xie J; Yang Z
    Aging (Albany NY); 2020 Nov; 12(23):23684-23697. PubMed ID: 33221740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
    Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
    Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
    [No Abstract]   [Full Text] [Related]  

  • 17. A20 attenuates hypoxia-induced pulmonary arterial hypertension by inhibiting NF-κB activation and pulmonary artery smooth muscle cell proliferation.
    Chen M; Ding Z; Zhang F; Shen H; Zhu L; Yang H; Chen S
    Exp Cell Res; 2020 May; 390(2):111982. PubMed ID: 32234376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.
    Hudalla H; Michael Z; Christodoulou N; Willis GR; Fernandez-Gonzalez A; Filatava EJ; Dieffenbach P; Fredenburgh LE; Stearman RS; Geraci MW; Kourembanas S; Christou H
    Am J Respir Cell Mol Biol; 2019 Oct; 61(4):512-524. PubMed ID: 30951642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Endothelium-Derived Wnt5a Is Associated With Reduced Pericyte Recruitment and Small Vessel Loss in Pulmonary Arterial Hypertension.
    Yuan K; Shamskhou EA; Orcholski ME; Nathan A; Reddy S; Honda H; Mani V; Zeng Y; Ozen MO; Wang L; Demirci U; Tian W; Nicolls MR; de Jesus Perez VA
    Circulation; 2019 Apr; 139(14):1710-1724. PubMed ID: 30586764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension.
    Chi PL; Cheng CC; Hung CC; Wang MT; Liu HY; Ke MW; Shen MC; Lin KC; Kuo SH; Hsieh PP; Wann SR; Huang WC
    Int J Biol Sci; 2022; 18(1):331-348. PubMed ID: 34975336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.